2nd Advances in Immuno-Oncology Congress

Join us at the 2nd Advances in Immuno-Oncology Congress
Join us at the 2nd Advances in Immuno-Oncology Congress 13/04/2017 07:56

 

HistologiX will be showcasing their Immuno-Oncology capability at this congress. Marie Cumberbatch (Director, Immune Insight) will be presenting a case study in NSCLC using IHC and state of the art digital image analysis

Oxford Global are proud to present the 2nd Annual Advances in Imuno-Oncology Congress taking place on 15-16 May 2017, London UK. Across the two days over 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling

4 interactive streams will cover:

• Discovery of Immuno-Oncology Therapies • Pre-clinical Immuno-Oncology • Screening, Assays and Modelling in Immuno-Oncology • Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials

For further information please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk

Link: http://www.immunooncology-congress.com/

Spotlight title

Antibodies intended for therapeutic clinical use must undergo screening in human tissue as part of any regulatory preclinical safety assessment.

Find out more

Tonsils; CD8_Foxp3 Dual Stain, Co-localisation analysis

Find out more